ORIGINAL RESEARCH article

Front. Immunol.

Sec. T Cell Biology

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1616491

This article is part of the Research TopicInnate and Adaptive Immunity of Normal and Adverse PregnancyView all 5 articles

Natural microbial exposure populates the maternal fetal interface with diverse T cells

Provisionally accepted
Amy  WhillockAmy Whillock1Perianne  SmithPerianne Smith2Sarah  BurgerSarah Burger1Adhvaith  SridharAdhvaith Sridhar3Alex  LindgrenAlex Lindgren3James  BergJames Berg4,5Sayaka  TsudaSayaka Tsuda6,7Shweta  MahajanShweta Mahajan6,8Tamara  TilburgsTamara Tilburgs6,8,9*Nathaniel  J SchuldtNathaniel J Schuldt1,10,11,2*
  • 1Department of Pediatrics, Medical School, University of Minnesota, Minneapolis, Minnesota, United States
  • 2Microbiology, Immunology, and Cancer Biology, University of Minnesota, Minneapolis, United States
  • 3College of Biological Sciences, University of Minnesota, Minnesota, Minnesota, United States
  • 4College of Veterinary Medicine, University of Minnesota, St Paul, Minnesota, United States
  • 5Comparative and Molecular Biosciences, College of Veterinary Medicine, University of Minnesota, Saint Paul, United States
  • 6Division of Immunobiology, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio, United States
  • 7Department of Obstetrics and Gynecology, Faculty of Medicine, University of Toyama, Toyama, Japan
  • 8Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
  • 9Center for Inflammation and Tolerance, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
  • 10Center for Immunology, Medical School, University of Minnesota, Minneapolis, Minnesota, United States
  • 11Masonic Cancer Center, Medical School, University of Minnesota, Minneapolis, Minnesota, United States

The final, formatted version of the article will be published soon.

Diverse T cell types accumulate at the human maternal fetal interface (MFI) during pregnancy to orchestrate immune tolerance for foreign fetal/placental tissues and immunity to pathogens. Yet, the dynamics of T cell influx and function at the MFI remain poorly defined. Conventional specific pathogen free (SPF) murine models fail to replicate the number and diversity of T cells in the human MFI, hindering mechanistic study of MFI T cells. Here we present an innovative use of a natural microbial exposure (NME) mouse model that enhances T cell influx and diversity in the MFI. We defined changes in the MFI of NME mice, relative to SPF mice and human tissues using transcriptomic and proteomic approaches. Physiological maternal microbial burden reproduced key features of human MFI immunology by i) significantly increasing the numbers and diversity of CD4 and CD8 effector and memory T cells at the MFI; ii) skewing the CD8 T cell composition towards tissue resident memory phenotypes with increased signatures of activation and dysfunction similar to human decidual T cells; and iii) expanding unconventional γδ T cells and Killer Lectin-like Receptors (KLR) expressing T cell types at the MFI, representative of an enhanced ability to interact with placental trophoblasts or infected cells. Thus, maternal microbial exposure induces vast changes to T cell numbers, diversity and functions at the MFI that models human MFI T cells with great fidelity. The NME model allows for improved translational investigation of the mechanisms of T cell tolerance, immunity, and inflammation in pregnancy.

Keywords: Pregnancy, T cells, Maternal fetal interface, dirty mice, Microbial exposure, Placenta, Decidua

Received: 22 Apr 2025; Accepted: 25 Jun 2025.

Copyright: © 2025 Whillock, Smith, Burger, Sridhar, Lindgren, Berg, Tsuda, Mahajan, Tilburgs and Schuldt. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Tamara Tilburgs, Division of Immunobiology, Cincinnati Children’s Hospital Medical Center, Cincinnati, 45229-3039, Ohio, United States
Nathaniel J Schuldt, Department of Pediatrics, Medical School, University of Minnesota, Minneapolis, 55454, Minnesota, United States

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.